Fatigue is very common in myelodysplastic syndromes (MDS) because anemia — low red blood cells — reduces oxygen delivery throughout your body, leaving you exhausted even after a full night’s sleep.

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

Dr. Shah was compensated by BMS for his participation. Photo Credit: Shutterstock As you age, feeling tired or short of breath may be dismissed as a part of getting older, but it’s important to talk ...

Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting Myelodysplastic syndromes (MDS) ...

Determining the roles that various inflammatory markers and pathways play in lower-risk myelodysplastic syndromes (MDS) could lead to therapies that keep disease progression at bay. This team ...

Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved ivosidenib for treatment of certain adults with relapsed or refractory myelodysplastic ...

Study findings provide new tools to assess treatment preferences when using hypomethylating agents in myelodysplastic syndromes (MDS). The study aimed to develop the TPMQ for clinicians (mTPMQ), ...

Centers for Medicare & Medicaid Services is considering expanding the national coverage determination for allogeneic hematopoietic stem cell transplants using bone marrow or peripheral blood stem cell ...